Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JMP Securities Maintains Market Outperform on Pardes Biosciences, Lowers Price Target to $5

JMP Securities Maintains Market Outperform on Pardes Biosciences, Lowers Price Target to $5

JMP Securities analyst Roy Buchanan maintains Pardes Biosciences (NASDAQ:PRDS) with a Market Outperform and lowers the price target from $9 to $5.

March 15, 2023

1 minute read

JMP Securities analyst Roy Buchanan maintains Pardes Biosciences (NASDAQ:PRDS) with a Market Outperform and lowers the price target from $9 to $5.

Jefferies Assumes Amphastar Pharmaceuticals at Buy, Announces Price Target of $36

October 21, 5:23 AM

Jefferies analyst Glen Santangelo assumes Amphastar Pharmaceuticals (NASDAQ:AMPH) with a Buy rating and announces Price Target of $36.

September 22, 8:20 AM

UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Buy and raises the price target from $66 to $70.

September 28, 10:00 AM

Over the past 3 months, 5 analysts have published their opinion on Apple Hospitality REIT (NYSE:APLE) stock. These…

July 27, 12:41 PM

Visa Inc (NYSE: V) shares are trading higher Wednesday after the company reported better-than-expected financial results.